Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger H Brookes

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Clinical and Vaccine Immunology : CVI|April 27, 2007
Extended culture enhances sensitivity of a gamma interferon assay for latent Mycobacterium tuberculosis infectionAna Cehovin, Jacqueline M Cliff, Philip C Hill, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2016
Screening Vaccine Formulations in Fresh Human Whole BloodJalil Hakimi, Sepideh Aboutorabian, Frederick To, et al.
Journal of Immunological Methods|June 5, 2021
Immunocartography: Charting vaccine-driven immunity by applying single cell proteomics to an in vitro human modelJessica S Duprez, Michael Cohen, Stephen Li, et al.
Human Vaccines & Immunotherapeutics|June 13, 2017
An adjuvant-modulated vaccine response in human whole bloodJalil Hakimi, Ali Azizi, Salvador F Ausar, et al.
European Journal of Immunology|November 25, 2003
CD8+ T cell-mediated suppression of intracellular Mycobacterium tuberculosis growth in activated human macrophagesRoger H Brookes, Ansar A Pathan, Helen McShane, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2003
Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus AnkaraNilu P Goonetilleke, Helen McShane, Carolyn M Hannan, et al.
Human Vaccines & Immunotherapeutics|April 28, 2015
Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodiesRoger H Brookes, Marin Ming, Kimberley Williams, et al.
Human Vaccines & Immunotherapeutics|May 22, 2015
A high ratio of IC31(®) adjuvant to antigen is necessary for H4 TB vaccine immunomodulationSepideh Aboutorabian, Jalil Hakimi, Florence Boudet, et al.
Immunology|July 24, 2004
Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulationHelen A Fletcher, Patrick Owiafe, David Jeffries, et al.
The Pediatric Infectious Disease Journal|May 23, 2013
Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in childrenAnnick Galetto-Lacour, Gabriel Alcoba, Klara M Posfay-Barbe, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Clinical and Vaccine Immunology : CVI|April 27, 2007
Extended culture enhances sensitivity of a gamma interferon assay for latent Mycobacterium tuberculosis infectionAna Cehovin, Jacqueline M Cliff, Philip C Hill, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2016
Screening Vaccine Formulations in Fresh Human Whole BloodJalil Hakimi, Sepideh Aboutorabian, Frederick To, et al.
Journal of Immunological Methods|June 5, 2021
Immunocartography: Charting vaccine-driven immunity by applying single cell proteomics to an in vitro human modelJessica S Duprez, Michael Cohen, Stephen Li, et al.
Human Vaccines & Immunotherapeutics|June 13, 2017
An adjuvant-modulated vaccine response in human whole bloodJalil Hakimi, Ali Azizi, Salvador F Ausar, et al.
European Journal of Immunology|November 25, 2003
CD8+ T cell-mediated suppression of intracellular Mycobacterium tuberculosis growth in activated human macrophagesRoger H Brookes, Ansar A Pathan, Helen McShane, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2003
Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus AnkaraNilu P Goonetilleke, Helen McShane, Carolyn M Hannan, et al.
Human Vaccines & Immunotherapeutics|April 28, 2015
Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodiesRoger H Brookes, Marin Ming, Kimberley Williams, et al.
Human Vaccines & Immunotherapeutics|May 22, 2015
A high ratio of IC31(®) adjuvant to antigen is necessary for H4 TB vaccine immunomodulationSepideh Aboutorabian, Jalil Hakimi, Florence Boudet, et al.
Immunology|July 24, 2004
Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulationHelen A Fletcher, Patrick Owiafe, David Jeffries, et al.
The Pediatric Infectious Disease Journal|May 23, 2013
Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in childrenAnnick Galetto-Lacour, Gabriel Alcoba, Klara M Posfay-Barbe, et al.
Pageof 4